Pluri (PLUR) Profit After Tax (2010 - 2025)
Pluri (PLUR) reported Profit After Tax of -$6.9 million for Q4 2025, down 132.48% year-over-year from $21.2 million in Q4 2024, and down 17.47% quarter-over-quarter from -$5.8 million in Q3 2025.
Pluri (PLUR) Profit After Tax (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Profit After Tax data on file, last reported at -$6.9 million in Q4 2025.
- Profit After Tax for Q4 2025 came in at -$6.9 million, down 132.48% year-over-year; the trailing twelve-month figure through Dec 2025 was -$26.2 million (down 28.15% YoY), and the FY2025 annual result was -$22.6 million, down 5.8% from the prior year.
- Profit After Tax eased to -$6.9 million in Q4 2025 per PLUR's latest filing, from -$5.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$3.0 million in Q4 2024 and troughed at -$14.6 million in Q2 2021.
- A 5-year average of -$7.7 million and a median of -$6.6 million in 2025 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax soared 46.46% in 2022, then sank 132.48% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$10.9 million in 2021, then climbed by 25.8% to -$8.1 million in 2022, then surged by 38.47% to -$5.0 million in 2023, then surged by 40.81% to -$3.0 million in 2024, then slumped by 132.48% to -$6.9 million in 2025.
- Business Quant data shows PLUR's Profit After Tax at -$6.9 million in Q4 2025, -$5.8 million in Q3 2025, and -$7.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -6.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.87 Mn |
| Sep 30, 2025 | -5.85 Mn |
| Jun 30, 2025 | -7.10 Mn |
| Mar 31, 2025 | -6.34 Mn |
| Dec 31, 2024 | -2.96 Mn |
| Sep 30, 2024 | -5.88 Mn |
| Jun 30, 2024 | -6.19 Mn |
| Mar 31, 2024 | -5.39 Mn |
| Dec 31, 2023 | -4.99 Mn |
| Sep 30, 2023 | -4.96 Mn |
| Jun 30, 2023 | -6.04 Mn |
| Mar 31, 2023 | -7.62 Mn |
| Dec 31, 2022 | -8.12 Mn |
| Sep 30, 2022 | -6.12 Mn |
| Jun 30, 2022 | -9.01 Mn |
| Mar 31, 2022 | -9.87 Mn |
| Dec 31, 2021 | -10.94 Mn |
| Sep 30, 2021 | -11.43 Mn |
| Jun 30, 2021 | -14.57 Mn |
| Mar 31, 2021 | -14.25 Mn |